ANGIODYNAMICS INC 4
4 · ANGIODYNAMICS INC · Filed Jul 24, 2015
Insider Transaction Report
Form 4
Richard Stark
SVP, GM - Oncology
Transactions
- Award
Common Stock
2015-07-22+4,287→ 32,988 total - Award
Non-Qualified Stock Option (right to buy)
2015-07-22+14,704→ 14,704 totalExercise: $15.95From: 2016-07-22Exp: 2022-07-22→ Common Stock (14,704 underlying) - Award
Performance Right
2015-07-22+5,716→ 5,716 total→ Common Stock (5,716 underlying)
Footnotes (3)
- [F1]This acquisition of 4,287 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 4,287 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 22, 2016, such that 25% of the restricted stock units will vest on each of July 22, 2016, 2017, 2018 and 2019.
- [F2]These stock options vest in four equal annual installments beginning on July 22, 2016, such that 25% of the options will vest on each of July 22, 2016, 2017, 2018 and 2019.
- [F3]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2016, 2017 and 2018. Any shares that do not vest at the end of the performance period will be forfeited.